BioMEMS for biosensors and closed-loop drug delivery

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Biosensors are crucial for personalized medicine, but traditional methods are often invasive or impractical.
• Microelectromechanical systems (MEMS) offer a pathway to miniaturize biosensors for improved physiological monitoring.
• Integrating biosensors with drug delivery systems enables closed-loop therapeutic interventions.

Purpose of the Study:

• To survey biosensing signal transduction devices implemented using MEMS technology.
• To discuss the impact of MEMS on biosensor development challenges.
• To highlight the potential of MEMS-based biosensors for enhanced pharmaceutical treatments.

Main Methods:

• Review of electrochemical, optical, and mechanical signal transduction methods for biosensing.
• Analysis of MEMS fabrication techniques for biosensor miniaturization and integration.
• Discussion of challenges including safety, power consumption, and foreign body response.

Main Results:

• MEMS technology enables the development of small, low-power biosensors with reduced implantation trauma and faster response times.
• MEMS fabrication facilitates mass production, scalability, and seamless integration with control and drug delivery systems.
• The technology addresses key challenges in biosensor development, improving reliability and performance.

Conclusions:

• MEMS technology is pivotal in advancing biosensor capabilities for personalized medicine.
• Miniaturized MEMS biosensors offer a viable solution for real-time physiological feedback and closed-loop drug delivery.
• Further research into MEMS-based biosensors promises significant improvements in pharmaceutical treatment efficacy and patient outcomes.